Literature DB >> 4063146

Time course of ovarian tumour growth in soft agar culture.

R H Verheijen, W F Feitz, P Kenemans, G P Vooys, C J Herman.   

Abstract

Single time point assessment is usually employed in the Human Tumour Cloning System as the only parameter for in vitro growth. This does not seem to give a fair expression of the dynamic biological properties of tumour growth and time dependent effects, e.g. of cytotoxic drugs. We studied the time course of colony formation in temporal growth patterns (TGPs) and compared this method of growth evaluation with conventional single time point assessment in 57 samples of ovarian tumour cultures in the HTCS. A first advantage of the use of TGPs is that more cultures become evaluable, as this assessment over time can detect a rise in the number of colonies in dishes where colony-like clumps have initially been seeded. Thus only 28 of the cultures were evaluable for single time point assessment, whereas 57 were available for TGP evaluation. Growth was more often seen at TGP evaluation (14/57) than at single day assessment (8/57). Evaluation of growth over the course of time potentially allows detection of sensitivity to drugs. Furthermore TGPs reflect the dynamics of biological growth. These features cannot be studied in single time point assessment.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4063146      PMCID: PMC1977227          DOI: 10.1038/bjc.1985.247

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  "Clumpogenic" v clonogenic assay.

Authors:  G Umbach; G Spitzer; B Drewinko
Journal:  Lancet       Date:  1983-09-10       Impact factor: 79.321

2.  Initial experience with the human tumor stem cell assay system: potential and problems.

Authors:  D D Von Hoff; G J Harris; G Johnson; D Glaubiger
Journal:  Prog Clin Biol Res       Date:  1980

3.  Direct cloning of human breast cancer in soft agar culture.

Authors:  J Sandbach; D D Von Hoff; G Clark; A B Cruz; M Obrien
Journal:  Cancer       Date:  1982-10-01       Impact factor: 6.860

4.  Cloning of human solid tumors in soft agar.

Authors:  D H Kern; M A Campbell; A J Cochran; M W Burk; D L Morton
Journal:  Int J Cancer       Date:  1982-12-15       Impact factor: 7.396

5.  'Viable' tumor cells in posttherapy biopsy specimens. A potential application of human tumor clonogenic cell culture.

Authors:  C J Herman; O Pelgrim; W J Kirkels; F M Debruyne; G P Vooijs
Journal:  Arch Pathol Lab Med       Date:  1983-02       Impact factor: 5.534

6.  Prospective clinical trial of a human tumor cloning system.

Authors:  D D Von Hoff; G M Clark; B J Stogdill; M F Sarosdy; M T O'Brien; J T Casper; D E Mattox; C P Page; A B Cruz; J F Sandbach
Journal:  Cancer Res       Date:  1983-04       Impact factor: 12.701

7.  Soft agar colony formation assay for in vitro testing of sensitivity to chemotherapy of gynecologic malignancies.

Authors:  T J Williams; M M Lieber; K C Podratz; G D Malkasian
Journal:  Am J Obstet Gynecol       Date:  1983-04-15       Impact factor: 8.661

8.  In-vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy.

Authors:  D S Alberts; S E Samon; H S Chen; E A Surwit; B Soehnlen; L Young; T E Moon
Journal:  Lancet       Date:  1980-08-16       Impact factor: 79.321

9.  Primary bioassay of human tumor stem cells.

Authors:  A W Hamburger; S E Salmon
Journal:  Science       Date:  1977-07-29       Impact factor: 47.728

10.  Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapy.

Authors:  D D Von Hoff; J Casper; E Bradley; J Sandbach; D Jones; R Makuch
Journal:  Am J Med       Date:  1981-05       Impact factor: 4.965

View more
  1 in total

1.  The in vitro effect of electromagnetically generated shock waves (Lithostar) on the Dunning R3327 PAT-2 rat prostatic cancer cell-line. A potentiating effect on the in vitro cytotoxicity of vinblastin.

Authors:  G O Oosterhof; G A Smits; J E de Ruyter; R J van Moorselaar; J A Schalken; F M Debruyne
Journal:  Urol Res       Date:  1989
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.